GMED

Globus Medical, Inc.
CAPPED RATING

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.

Globus Medical, Inc. (GMED) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Revisions (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
B
Factor Score 3.2 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
B
Factor Score 3.5 / 5.0
Momentum
C+
Factor Score 2.8 / 5.0
Revisions
F
Factor Score 0.2 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 17.8
EV / EBITDA 8.9
Rev Growth YoY -0.7%
Gross Margin 69.3%
Price Return 3M -15.3%
Price Return 12M -14.8%
Catalyst Signal -0.02
Market Cap $9.6B
TTM Revenue $3.1B
Price / Sales 3.0
ROE 12.1%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 B (3.2) C- (2.1) B (3.5) C+ (2.8) F (0.2) C (2.3)
2026-11-09 B (3.2) C- (2.1) B (3.4) C+ (2.6) F (0.2) C (2.3)
2026-11-07 B- (3.1) C- (1.9) B (3.5) C+ (2.6) D (1.5) C+ (2.5)
2026-11-06 B- (3.1) C- (1.9) B (3.4) C+ (2.6) D+ (1.6) C+ (2.5)
2026-11-02 B- (3.1) C- (1.9) B (3.4) C+ (2.6) D+ (1.7) C+ (2.5)
Page 1 of 10
…